Digital health provider Clarity Pediatrics has raised $10m in seed funding round to enhance its virtual attention deficit hyperactivity disorder (ADHD) care platform for children.
The latest investment round was led by US-based venture capital company Rethink Impact, with contributions from Homebrew, Maverick Ventures, Vamos Ventures, January Ventures, Alumni Ventures, and Citylight VC.
Go deeper with GlobalData
All these investors will join Clarity Pediatrics’ group of angel investors, including healthcare leaders from organisations such as Rock Health, CityBlock, Quartet, Livongo, Solv, among others.
Clarity will utilise the latest infusion to launch new clinical service lines, improve its care platform, and expand its geographic presence.
The company plans to broaden its ADHD care platform, providing families with access to virtual group therapy support and medication management for paediatric ADHD.
Clarity’s ADHD care platform currently offers 12 months of virtual group therapy, focusing on skill-building programmes to tackle executive function challenges and emotional dysregulation.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe company has also introduced medication management services for paediatric ADHD.
Launched in 2021, Clarity Pediatrics was co-founded by paediatric specialist Dr Alesandro Larrazabal, who most recently served as medical director at Kaiser Permanente.
Clarity Pediatrics is dedicated to transforming paediatric chronic care across multiple specialities, beginning with ADHD.
The company is working to develop a virtual paediatric clinic that is both recommended by paediatricians and trusted by parents, leveraging a tech-enabled clinical model.
Its approach, centred around Behavioural Parent Training (BPT), aims to make ADHD care ten times more accessible and 20 times more affordable, offering next-day appointments and an average co-pay of $15 per session.
Soon, the company also plans to expand its paediatric care platform to additional chronic conditions, such as obesity, asthma, and allergies.
Clarity Pediatrics CEO and co-founder Christina LaMontagne said: “Clarity Pediatrics integrates with referring paediatricians, so families stay close to their doctor and physicians get additional support. We’ve made the impossible now possible for thousands of families experiencing ADHD: affordable, expert diagnosis and multi-speciality treatment, coordinated on a single, convenient platform, with no waitlists.”
